AUSBIO 2020 Sessions: Trends in APAC Cell Therapy Supply Chain

By Alex Guite; Kelly Frend |

AUSBIO 2020 Sessions 2 of 3

We concluded our AUSBIO 2020 Conference in late October, and we shared many insights on the pharmaceutical supply chain, Direct-to-patient logistics and Cell & Gene Therapy for APAC.

Our second session, Trends in APAC's Cell Therapy Supply Chain is now available to view on-demand. Please fill in your details below to hear from Alex Guite, Vice President, Services and Alliances.

Duration: 25 mins

The webinar details the following topics:

  • Growth in Cell and Gene Therapy in Asia Pacific
  • Lessons Learnt: Plan Early for Success, Be Thoughtful about Data, Clinical Trials vs Scale at Commercialization
  • Q&A

About the Authors

Portrait of Alex Guite.

Alex Guite

Vice President, Services and Alliances
World Courier
View Bio

Kelly Frend

Specialty Services Manager
World Courier
Kelly is Specialty Services Manager and Subject Matter Expert for Direct-to-Patient and Cell and Gene Therapy at World Courier. Kelly has nearly 14 years of experience within the specialty transport and logistics industry. At World Courier, Kelly is a subject matter expert in temperature-controlled logistics, with a deep knowledge of Direct-to-Patient and Cell and Gene Therapy supply chains. She is responsible for leading the WEMEA region by overseeing all specialty service offerings within this area. She maintains a thorough understanding of the regulatory landscape and drives improvement initiatives that ensure all customers receive the highest level of service at all times.
View Bio